Immune Profiles in Multisystem Inflammatory Syndrome in Children with Cardiovascular Abnormalities

Area of Science:

• Pediatric immunology
• Infectious disease pathology
• Cytokine and chemokine research

Background:

• Multisystem inflammatory syndrome in children (MIS-C) is a serious complication following SARS-CoV-2 infection.
• Cardiac involvement is frequent in MIS-C, but immunological distinctions between cardiac and non-cardiac forms are unclear.
• Understanding these immunological differences is crucial for managing MIS-C.

Purpose of the Study:

• To differentiate the immunological profiles of MIS-C with cardiac involvement versus MIS-C without cardiac involvement.
• To identify specific cytokines and chemokines associated with cardiac manifestations in MIS-C.
• To contribute to the understanding of MIS-C immunopathogenesis, particularly in low- and middle-income countries.

Main Methods:

• Analyzed levels of various cytokines (Type 1, 2, 17, pro-inflammatory) and chemokines (CC, CXC) in MIS-C patients.
• Utilized the Magpix multiplex cytokine assay system for measurements.
• Compared immune markers in children with MIS-C cardiac (n=88) and MIS-C non-cardiac (n=64) conditions.

Main Results:

• Children with cardiac MIS-C exhibited significantly higher levels of numerous cytokines (e.g., IFN-γ, IL-6, TNFα) and chemokines (e.g., CCL2, CXCL10).
• Clustering analysis confirmed that cytokine and chemokine patterns effectively distinguished between cardiac and non-cardiac MIS-C.
• Immune responses in MIS-C patients significantly decreased and normalized approximately 9 months post-treatment.

Conclusions:

• This study provides novel insights into the systemic inflammation differentiating cardiac from non-cardiac MIS-C.
• It is among the first studies from a low- and middle-income country to characterize these immunological differences.
• The findings advance the knowledge of MIS-C immunopathogenesis and highlight the potential for immune marker normalization post-treatment.